- Home
- NVCT vs FMN Comparison
NVCT vs FMN Comparison
Compare NVCT & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- FMN
- Stock Information
- Founded
- NVCT 2020
- FMN 2002
- Country
- NVCT United States
- FMN United States
- Employees
- NVCT N/A
- FMN N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- FMN Investment Managers
- Sector
- NVCT Health Care
- FMN Finance
- Exchange
- NVCT Nasdaq
- FMN Nasdaq
- Market Cap
- NVCT 119.4M
- FMN 127.6M
- IPO Year
- NVCT 2022
- FMN N/A
- Fundamental
- Price
- NVCT $4.52
- FMN $10.95
- Analyst Decision
- NVCT Strong Buy
- FMN
- Analyst Count
- NVCT 1
- FMN 0
- Target Price
- NVCT $21.00
- FMN N/A
- AVG Volume (30 Days)
- NVCT 94.6K
- FMN 22.8K
- Earning Date
- NVCT 11-05-2024
- FMN 01-01-0001
- Dividend Yield
- NVCT N/A
- FMN 3.86%
- EPS Growth
- NVCT N/A
- FMN N/A
- EPS
- NVCT N/A
- FMN N/A
- Revenue
- NVCT N/A
- FMN N/A
- Revenue This Year
- NVCT N/A
- FMN N/A
- Revenue Next Year
- NVCT N/A
- FMN N/A
- P/E Ratio
- NVCT N/A
- FMN N/A
- Revenue Growth
- NVCT N/A
- FMN N/A
- 52 Week Low
- NVCT $4.44
- FMN $9.09
- 52 Week High
- NVCT $12.10
- FMN $11.31
- Technical
- Relative Strength Index (RSI)
- NVCT 37.50
- FMN 27.60
- Support Level
- NVCT $4.48
- FMN $11.45
- Resistance Level
- NVCT $5.34
- FMN $11.58
- Average True Range (ATR)
- NVCT 0.37
- FMN 0.10
- MACD
- NVCT 0.07
- FMN -0.04
- Stochastic Oscillator
- NVCT 8.89
- FMN 5.97
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers.. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.